<?xml version="1.0" encoding="UTF-8"?><?xml-model type="application/xml-dtd" href="http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" dtd-version="1.1d3" specific-use="Marcalyc 1.2" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="redalyc">647</journal-id>
<journal-title-group>
<journal-title specific-use="original" xml:lang="es">Universitas Psychologica</journal-title>
<abbrev-journal-title abbrev-type="publisher" xml:lang="es">Univ. Psychol.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">1657-9267</issn>
<issn pub-type="epub">2011-2777</issn>
<publisher>
<publisher-name>Pontificia Universidad Javeriana</publisher-name>
<publisher-loc>
<country>Colombia</country>
<email>revistascientificasjaveriana@gmail.com</email>
</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="art-access-id" specific-use="redalyc">64752604016</article-id>
<article-id pub-id-type="doi">http://dx.doi.org/10.11144/Javeriana.upsy16-3.rpsf</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Sin sección</subject>
</subj-group>
</article-categories>
<title-group>
<article-title xml:lang="en">Risk perception in subjects at-risk for Familial Amyloidotic Polyneuropathy<xref ref-type="fn" rid="fn1">*</xref>
</article-title>
<trans-title-group>
<trans-title xml:lang="es">Percepción del riesgo en sujetos con riesgo de
Polineuropatía Amiloide Familiar</trans-title>
</trans-title-group>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="ORCID">http://orcid.org/0000-0003-0560-1756</contrib-id>
<name name-style="western">
<surname>Leite</surname>
<given-names>Ângela</given-names>
</name>
<xref ref-type="corresp" rid="corresp1"/>
<xref ref-type="aff" rid="aff1"/>
<email>angelamtleite@gmail.com</email>
</contrib>
<contrib contrib-type="author" corresp="no">
<name name-style="western">
<surname>Pimenta Dinis</surname>
<given-names>Maria Alzira</given-names>
</name>
<xref ref-type="aff" rid="aff2"/>
</contrib>
<contrib contrib-type="author" corresp="no">
<name name-style="western">
<surname>Sequeiros</surname>
<given-names>Jorge</given-names>
</name>
<xref ref-type="aff" rid="aff3"/>
<xref ref-type="aff" rid="aff4"/>
</contrib>
<contrib contrib-type="author" corresp="no">
<name name-style="western">
<surname>Paúl</surname>
<given-names>Constança</given-names>
</name>
<xref ref-type="aff" rid="aff5"/>
</contrib>
</contrib-group>
<aff id="aff1">
<institution content-type="original">European University of  Lisbon, Portugal</institution>
<institution content-type="orgname">European University of  Lisbon</institution>
<country country="pt">Portugal</country>
</aff>
<aff id="aff2">
<institution content-type="original">UFP Energy, Environment and Health Research Unit (FP-ENAS), Porto,
Portugal</institution>
<institution content-type="orgname">UFP Energy, Environment and Health Research Unit (FP-ENAS)</institution>
<country country="pt">Portugal</country>
</aff>
<aff id="aff3">
<institution content-type="original">Institute for Molecular and Cell Biology, Portugal</institution>
<institution content-type="orgname">nstitute for Molecular and Cell Biology</institution>
<country country="pt">Portugal</country>
</aff>
<aff id="aff4">
<institution content-type="original">Instituto de Ciências Biomédicas Salazar (ICBAS), Portugal</institution>
<institution content-type="orgname">Instituto de Ciências Biomédicas Salazar (ICBAS)</institution>
<country country="pt">Portugal</country>
</aff>
<aff id="aff5">
<institution content-type="original">Instituto de Ciências Biomédicas Salazar (ICBAS), Portugal</institution>
<institution content-type="orgname">Instituto de Ciências Biomédicas Salazar (ICBAS)</institution>
<country country="pt">Portugal</country>
</aff>
<author-notes>
<corresp id="corresp1">
<email>Correspondance autor: E-mail:
angelamtleite@gmail.com</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<year>2017</year>
</pub-date>
<volume>16</volume>
<issue>3</issue>
<history>
<date date-type="received" publication-format="dd mes yyyy">
<day>13</day>
<month>10</month>
<year>2015</year>
</date>
<date date-type="accepted" publication-format="dd mes yyyy">
<day>15</day>
<month>02</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-year>no</copyright-year>
<ali:free_to_read/>
<license xlink:href="https://creativecommons.org/licenses/by/4.0/">
<ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>Esta obra está bajo una Licencia Creative Commons Atribución 4.0 Internacional.</license-p>
</license>
</permissions>
<abstract xml:lang="en">
<title>Abstract</title>
<p> The aims of this study are to know if subjects at-risk were aware of their 50% risk for Familial Amyloidotic Polyneuropathy (FAP); to know the value of the subjective risk; to understand the association between sociodemographic characteristics and risk perception, and between the risk status and the subjective perception of risk. 174 subjects 50% at-risk for FAP were tested. 52.9% subjects at-risk were aware of their 50% risk condition. The mean value of the subjective risk was higher and closer to 50% when the subjects were aware of their 50% risk condition. Education was associated to a higher awareness of being at 50% risk. It seems that information on previous knowledge before performing the genetic counselling increases the subjective risk.</p>
</abstract>
<trans-abstract xml:lang="es">
<title>Resumen</title>
<p> Los objetivos de este estudio son saber si los sujetos en riesgo eran conscientes de su riesgo del 50% para la polineuropatía amiloide familiar (PAF); conocer el valor del riesgo subjetivo; y comprender la asociación entre las características sociodemográficas y la percepción del riesgo y entre el riesgo real y la percepción subjetiva del riesgo. Se examinaron 174 sujetos con riesgo de PAF del 50%. 52,9% de los sujetos en riesgo eran conscientes de su condición de riesgo del 50%. El valor medio del riesgo subjetivo fue mayor y más cercano al 50% cuando los sujetos eran conscientes de su condición de riesgo del 50%. La educación se asoció a una mayor conciencia de estar al 50% de riesgo. Parece que la información sobre los conocimientos previos antes de realizar el asesoramiento genético aumenta el riesgo subjetivo.</p>
</trans-abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Risk perception</kwd>
<kwd> psychological risk</kwd>
<kwd> subjective risk</kwd>
<kwd> objective risk</kwd>
<kwd> familial amyloidotic polyneuropathy (FAP)</kwd>
</kwd-group>
<kwd-group xml:lang="es">
<title>Palabras clave</title>
<kwd>Percepción del riesgo</kwd>
<kwd> riesgo psicológico</kwd>
<kwd> riesgo subjetivo</kwd>
<kwd> riesgo objetivo</kwd>
<kwd> polineuropatía amiloide familiar (PAF)</kwd>
</kwd-group>
<counts>
<fig-count count="0"/>
<table-count count="3"/>
<equation-count count="0"/>
<ref-count count="33"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>How to cite</meta-name>
<meta-value>Leite, Â., Pimenta, M. A., Sequeiros, J., Paíl, C. (2017). Risk perception in
subjects at-risk for Familial Amyloidotic Polyneuropathy. <italic>Universitas
Psychologica</italic>, <italic>16</italic>(3), xx-xx.  <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.11144/Javeriana.upsy16-3.rpsf">https://doi.org/10.11144/Javeriana.upsy16-3.rpsf</ext-link> </meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
		
		<sec>
            <title>Introduction</title>
			
		<p> Risk perception is understood as the ability of a subject to discern a certain amount of risk, while risk tolerance refers to a person’s capacity to accept a certain amount of risk (<xref ref-type="bibr" rid="redalyc_64752604016_ref14">Inouye, 2014</xref>). Accordingly, the risk that exists independently of a subject’s knowledge and worries of the source of the risk is known as objective risk (<xref ref-type="bibr" rid="redalyc_64752604016_ref31">Ulleberg &amp; Rundmo, 1996</xref>). Thus, the perceived risk, or subjective risk, is a reflection of the real risk, especially when risks are well-known (<xref ref-type="bibr" rid="redalyc_64752604016_ref26">Sjöberg, Moen, &amp; Rundmo, 2004</xref>). In other words, humans perceive and act on risk in two ways: <italic>risk as feelings</italic> refers to subjects’ instinctive and intuitive reactions to danger; <italic>risk as analysis</italic> refers to logic, reason, and scientific deliberation to take into account on risk management. Reliance on risk as feelings is described as “the affect heuristic” (<xref ref-type="bibr" rid="redalyc_64752604016_ref29">Slovic &amp; Peters, 2006</xref>). However, <xref ref-type="bibr" rid="redalyc_64752604016_ref28">Slovic and Elke (2002)</xref> stated that risk does not exist “out there”, independently of people’s minds and cultures, waiting to be measured. Instead, it is seen as a concept that helps to understand and cope with the dangers and uncertainties of life. <xref ref-type="bibr" rid="redalyc_64752604016_ref7">Darker and Phillips (2016)</xref> stated that there are three dimensions of perceived risk: perceived likelihood, i.e. the probability that one will be harmed by the hazard; perceived susceptibility, i.e. an individual’s constitutional vulnerability to a hazard; and perceived severity, i.e. the extent of harm a hazard would cause. It is clear that the level of perceived risk of a new technology or product may be considered an important early indicator of the public’s alertness to its potential hazards (<xref ref-type="bibr" rid="redalyc_64752604016_ref24">Sjöberg, 2004</xref>). </p>
<p> Risk perception has become increasingly important in the last years, receiving particular attention for its influence on the attitudes and decisions of subjects and social groups regarding the acceptance of various modern technologies and activities, such as nuclear energy and gene technology (<xref ref-type="bibr" rid="redalyc_64752604016_ref1">Al-Rawad &amp; Al Khattab, 2015</xref>). A culturally sensitive mid-range theory of risk perception, recently proposed by <xref ref-type="bibr" rid="redalyc_64752604016_ref23">Siaki, Loescher and Trego (2013)</xref>, suggests that risk appraisals are influenced by affect, health-world views, cultural customs, and protocols that intersect with the health risk. On the other hand, trust in the science behind risk assessments and risk management is possibly more important than social trust, although both types of trust should be considered (<xref ref-type="bibr" rid="redalyc_64752604016_ref25">Sjöberg, 2012</xref>).</p>
<p> As a consequence of the growth of knowledge and of an increasing number of genetic tests, genetic counseling can be offered to more and more subjects, couples and families (<xref ref-type="bibr" rid="redalyc_64752604016_ref9">Evers-Kiebooms &amp; Decruyenaere, 1998</xref>). Predictive DNA-tests may provide information about the "future health status" of an asymptomatic person (<xref ref-type="bibr" rid="redalyc_64752604016_ref11">Evers-Kiebooms, Welkenhuysen, Claes, Decruyenaere, &amp; Denayer, 2000</xref>). The "not-yet-ill" is a rather peculiar expression used to describe a new social category of subjects (<xref ref-type="bibr" rid="redalyc_64752604016_ref15">Jamieson, 2001</xref>). Understanding how people adapt to and manage inherited risk would be useful in the planning and provision of genetics health services (<xref ref-type="bibr" rid="redalyc_64752604016_ref8">Etchegary, 2011</xref>). </p>
<p> Familial Amyloidotic Polyneuropathy (FAP) is a progressive neurodegenerative disease, inherited as an autosomal dominant trait (<xref ref-type="bibr" rid="redalyc_64752604016_ref5">Coutinho, 1976</xref>). It is a late onset disease with no cure, although there are already two types of treatment, liver transplantation and a new drug, Tafamidis (<xref ref-type="bibr" rid="redalyc_64752604016_ref4">Coelho et al., 2012</xref>). However, these two different therapeutic approaches do not heal the patients. Instead, they just prevent the disease progression and delay its development. </p>
<p> A protocol of genetic counselling and psychosocial evaluation and support, before and after pre-symptomatic testing (PST), is thought to be important to a healthy adjustment to the test results (<xref ref-type="bibr" rid="redalyc_64752604016_ref22">Sequeiros, 1996</xref>). The multidisciplinary approach to predictive testing for the Huntington Disease (HD) has been used as a model for predictive testing for other late onset neurodegenerative diseases (<xref ref-type="bibr" rid="redalyc_64752604016_ref10">Evers-Kiebooms &amp; Fryns, 1999</xref>). According to <xref ref-type="bibr" rid="redalyc_64752604016_ref21">Quaid et al. (2008)</xref>, people at-risk for HD bear a greater burden regarding concealment and disclosure than do people at risk for other chronic or life-threatening conditions. The choice of performing the predictive testing should be a well-informed, free, and personal decision of the test applicant without external pressure (<xref ref-type="bibr" rid="redalyc_64752604016_ref11">Evers-Kiebooms et al., 2000</xref>).</p>
<p> According to <xref ref-type="bibr" rid="redalyc_64752604016_ref2">Brewer et al. (2007)</xref>, risk perception is central to most health-specific behavioural theories. Thus, all the health professionals working with families who may apply for or are already involved in predictive testing, should be aware of the psychological meaning of genetic risk and genetic test results (<xref ref-type="bibr" rid="redalyc_64752604016_ref11">Evers-Kiebooms et al., 2000</xref>). People’s emotional reactions to risk often depend on the vividness with which negative consequences can be imagined or experienced (<xref ref-type="bibr" rid="redalyc_64752604016_ref32">Weber, 2006</xref>). Indeed, and according to <xref ref-type="bibr" rid="redalyc_64752604016_ref16">Joffe (2003)</xref>, the way in which people approach and evaluate risks is influenced by other people. That is why risk perceptions are probably more important when people make individual decisions about a behavior with relatively diffuse external influences (<xref ref-type="bibr" rid="redalyc_64752604016_ref2">Brewer et al., 2007</xref>). Disagreements about risk should not be expected to disappear in the presence of evidence. According to <xref ref-type="bibr" rid="redalyc_64752604016_ref27">Slovic (1987)</xref>, strong initial views before performing predictive testing are resistant to change because they are able to influence the way subsequent information is interpreted. Accordingly, there are many interwoven social, biographical, and temporal factors which shape and differentiate the relevance of hereditary risk (<xref ref-type="bibr" rid="redalyc_64752604016_ref6">Cox &amp; McKellin, 1999</xref>).</p>
<p> It is extremely important to realise what is the psychological meaning of being at 50% risk for FAP. This risk influences the entire life of the subject at-risk for this specific disease. Although the risk to develop the disease decreases gradually with age, at-risk subjects for FAP are never entirely sure that they have escaped the disease. In fact, the variable age of onset is an additional source of uncertainty (<xref ref-type="bibr" rid="redalyc_64752604016_ref11">Evers-Kiebooms et al., 2000</xref>) and each son or daughter of an affected person has a 50% chance of developing any of these diseases and is often referred to as “being at-risk”, a state described as living with an abiding sense of impending threat, according to <xref ref-type="bibr" rid="redalyc_64752604016_ref30">Taylor (2003)</xref> and <xref ref-type="bibr" rid="redalyc_64752604016_ref33">Wexler (1979)</xref>. Moreover, the additional psychological risk should not be underestimated (<xref ref-type="bibr" rid="redalyc_64752604016_ref12">Folstein, Franz, Jensen, Chase, &amp; Folstein, 1983</xref>), although a subject prediction about the exact age of onset, the specific symptoms of the disease or its evolution is impossible. This means that a degree of uncertainty will always persist (<xref ref-type="bibr" rid="redalyc_64752604016_ref9">Evers-Kiebooms &amp; Decruyenaere, 1998</xref>). Some untested subjects at-risk are aware of their 50% risk, and some are not. However, both groups evaluate the subjective risk in a different way. According to <xref ref-type="bibr" rid="redalyc_64752604016_ref3">Cantor and Norem (1989)</xref>, overestimation and underestimation of the risk has occurred in untested persons, although the majority of the subjects usually overestimates the benefits and underestimates the harm of treatments, screening, and tests (<xref ref-type="bibr" rid="redalyc_64752604016_ref13">Hoffmann &amp; Del Mar, 2015</xref>).</p>
<sec>
<title>The present study</title>
<p> The aims of the study are mainly four (i) to estimate how many subjects at-risk are aware of their 50% risk condition; (ii) to estimate the subjective risk of subjects at-risk; (iii) to verify if there is any association between the sociodemographic characteristics of the subjects and their risk perception; and (iv) to clarify the association between the risk status and the subjective perception of risk.</p>
<p> The considered hypothesis are two: (i) subjects at-risk who perform the PST, already aware of their 50% risk condition, will estimate their risk closer to 50% than the subjects at-risk who are not aware of their risk status, and (ii) subjects at-risk who undergo the PST, aware of their 50% risk, will estimate their risk lower than the subjects at-risk who are not aware of their risk status.</p>
</sec>
</sec>
	<sec>
<title>Methods</title>
<sec>
<title>Participants</title>
<p>174 subjects at-risk, presenting a genetic risk of 50% for FAP, were studied. Subjects at-risk with a genetic risk of 50% are the subjects who descend from a progenitor, or had at least one brother with a molecular diagnosis of carrier. These subjects were asymptomatic, aged equal or older than 18 years and they had not been yet tested for the disease. The definition of 18 years as the minimum age to participate in this study is related with ethical and legal problems arising when persons ask for genetic testing for persons younger than 18 years. Exceptionally, young people aged 17 are accepted if they become 18 during the genetic counselling process. All the subjects at-risk were registered in the genetic counselling programme of the Center for Predictive and Preventive Genetics (CGPP), in order to know their genetic status, and have accepted to participate in the present study. </p>
<p> The studied sample included 104 (60%) women and 70 (40%) men. The age ranged between 17 and 66 years, with a mean age of 27.40 (<italic>SD</italic> = 10.38). 165 (95%) subjects at-risk have Portuguese nationality and the rest have foreign nationality. Of the total sample, one subject (1%) is illiterate, 76 (47%) subjects have basic education, 44 (25%) subjects have the 9<sup>th</sup> grade, 41 (24%) subjects have the 12<sup>th</sup> grade, and 12 (7%) subjects have a university education.</p>
</sec>
<sec>
<title>Design and procedure</title>
<p>The
study was based on a protocol designed and conceived by the authors to study
the awareness, knowledge, and attitudes of Portuguese people concerning the
genetic testing for inherited progressive neurodegenerative late onset diseases.
All individuals have attended consultations for genetic counselling in the
Center for Preventive and Predictive Genetics, Institute for Molecular and Cell
Biology, in order to know their genetic risk for the disease or to know the
risk to transmit the disease. This study’s protocol is applied immediately
before the first counselling protocol session. One of the protocol’s issues
concerns risk perception. The subjective perception of this risk was assessed
with a closed question and a task: subjects at-risk were encouraged to choose
between two options - whether they were aware or not of their risk condition
and then they had to estimate their subjective risk by marking a cross in a
line that starts begging with a 0% risk and ends at a 100% risk, with major
tick marks every 10% (<xref ref-type="table" rid="gt1">Table 1</xref>). All subjects have been explained the specific
nature of the research, the objectives of the study and the type of treatment
to be given to the data. The confidentiality of the data was made clear. The
informed consent to voluntary collaborate in the research was also obtained.</p>
<p>
<table-wrap id="gt1">
<label>TABLE 1</label>
<caption>
<title>Risk perception</title>
</caption>
<alt-text>TABLE 1 Risk perception</alt-text>
<graphic xlink:href="64752604016_gt1.jpg" position="anchor" orientation="portrait"/>
<attrib>Source: own
work</attrib>
</table-wrap>
</p>
</sec>
</sec>
<sec>
<title>Results</title>
<p> From a total number of 174 (100%) subjects at-risk for FAP, 159 (91%) answered whether they were or not informed about their risk, until the moment they were being questioned about it. The remaining 15 (9%) subjects at-risk did not understand the question and, for that reason, their answer was not taken into account. Among the 159 subjects that answered about their awareness of the risk, 92 (53%) were aware of their 50% condition of genetic risk, and 67 (39%) were not. </p>
<p> The value of the subjective risk is higher (51%) and closer to 50% when the subjects are aware of their 50% risk condition, than when they were not (45%). There are significant statistical differences regarding the subjective risk, between the subjects that were aware of their 50% risk condition and those who were not [<italic>F</italic> (1.157) = 4.143, <italic>p</italic> &lt; 0.050)].</p>
<p> Analyzing <xref ref-type="table" rid="gt2">Table 2</xref>, it is possible to observe that subjects who were aware of their 50% risk condition had more education than the subjects who were not aware. Gender, age, and nationality did not influence the choice of the risk perception’s value.</p>
<p>
<table-wrap id="gt2">
<label>TABLE 2</label>
<caption>
<title>Characterization of the sample
regarding risk awareness (n = 159)</title>
</caption>
<alt-text>TABLE 2 Characterization of the sample
regarding risk awareness (n = 159)</alt-text>
<graphic xlink:href="64752604016_gt2.jpg" position="anchor" orientation="portrait"/>
<attrib>Source: own work.</attrib>
<table-wrap-foot>
<fn-group>
<fn id="fn3" fn-type="other">
<label/>
<p>
<italic>n</italic> sample size; <italic>F</italic> Snedcor's <italic>F</italic>-distribution; <italic>p p</italic>-value; <italic>η<sup>2</sup>
</italic> = eta squared </p>
</fn>
</fn-group>
</table-wrap-foot>
</table-wrap>
</p>
<p>The difference between the
subjective value of the risk for FAP cannot be considered statistically
significant regarding gender, nationality, and education (women, foreign
citizen, and more educated people present the highest values). On the contrary,
significantly different values are found regarding age, since older subjects
tend to choose a higher value of subjective risk (<xref ref-type="table" rid="gt3">Table 3)</xref>.</p>
<p>
<table-wrap id="gt3">
<label>TABLE 3</label>
<caption>
<title>Characterization of
the sample according to the value of subjective risk (n = 174)</title>
</caption>
<alt-text>TABLE 3 Characterization of
the sample according to the value of subjective risk (n = 174)</alt-text>
<graphic xlink:href="64752604016_gt3.jpg" position="anchor" orientation="portrait"/>
<attrib>Source: own
work.</attrib>
<table-wrap-foot>
<fn-group>
<fn id="fn4" fn-type="other">
<label/>
<p>
<italic>n</italic> sample size; <italic>F</italic> Snedcor's <italic>F</italic>-distribution; <italic>p p</italic>-value; <italic>η<sup>2</sup>
</italic> = eta squared</p>
</fn>
</fn-group>
</table-wrap-foot>
</table-wrap>
</p>
</sec>
<sec>
<title>Discussion</title>
<p> The first hypothesis, based on the idea that subjects at-risk, who perform the PST aware of their 50% risk condition, will estimate their risk closer to 50% than the subjects at-risk who are not aware of their risk status, has been confirmed. In fact, the subjective risk is closer to 50% (52%) when the subjects are aware of their 50% risk than when they are not (45%) and the difference is significant. It means that the knowledge of the real risk condition (50%) influences the subjective perception of the risk when compared with the risk perception of those subjects who did not know their real risk condition previously to performing the PST: the knowledge of the objective risk takes subjects to perceive risk closer to the value of the objective risk. This may happen because previous knowledge is usually supported by trained professionals. And, although the communication of the risk may have been misunderstood by the subjects at-risk -because it was not properly contextualized or explained, which can lead to overestimation or underestimation of the risk, according to <xref ref-type="bibr" rid="redalyc_64752604016_ref3">Cantor and Norem (1989)</xref>- the subjects previously informed about the objective risk tend to retain the value and evoke it when asked about it.</p>
<p> The second hypothesis, based on the idea that subjects at-risk who perform the PST aware of their 50% risk condition will estimate a lower risk than the subjects at-risk who are not aware of their risk status, has not been proved. On the contrary, the subjects at-risk conscious of their 50% objective risk estimated a higher risk value than those who were not aware of the objective risk value. <xref ref-type="bibr" rid="redalyc_64752604016_ref13">Hoffmann and Del Mar (2015)</xref> may help to explain why that happens, when they state that the majority of the subjects usually overestimates the benefits and underestimates the harm of treatments, screening, and tests.</p>
<p> Subjects who were aware of their 50% risk condition had more education than the subjects who were not aware. More educated subjects have a significant amount of previous information regarding the objective risk than those with less education. This is in agreement with the statements of <xref ref-type="bibr" rid="redalyc_64752604016_ref23">Siaki et al. (2013)</xref>, who suggest that risk appraisals are influenced by affect, health-world views, cultural customs, and protocols that intersect with the health risk. The fact that more educated subjects are more informed than the less educated ones may suggest that education can act as a filter of media information, since one of the effects of the media attention, that has undoubtedly accompanied genetics advances, is the increasing anxiety among a wider range of subjects at-risk (<xref ref-type="bibr" rid="redalyc_64752604016_ref18">Patenaude, Guttmacher, &amp; Collins, 2002</xref>). According to <xref ref-type="bibr" rid="redalyc_64752604016_ref20">Petersen (2001)</xref>, anxiety about genetic health risks may occur even in people for whom genetic testing or treatment is not yet an option. This anxiety may be due in part to misconceptions about current genetic knowledge, fuelled by some overly optimistic press reports. Given the vast amount of genetic information available on the scientific literature and on the internet in general, it has been postulated the usefulness for mental health professionals to be able to help patients seeking further knowledge from legitimate resources (<xref ref-type="bibr" rid="redalyc_64752604016_ref18">Patenaude et al., 2002</xref>).</p>
<p> Older subjects tend to choose a higher value of subjective risk than younger ones. Perhaps it might be stated that older people have less risk tolerance, when considering what <xref ref-type="bibr" rid="redalyc_64752604016_ref14">Inouye (2014)</xref> claims, when defining risk tolerance as the person’s capacity to accept a certain amount of risk. Working through worst-case scenarios provides an element of control for the subjects. They prepare themselves for the worst, which may consist in a bad test result, the onset of the disease, and then try to come to terms with it (<xref ref-type="bibr" rid="redalyc_64752604016_ref17">Lippman-Hand &amp; Fraser, 1979</xref>). That may also be explained by keeping in mind that overestimation of the risk occurs more than underestimation, and this may also suggest that some persons at-risk adopt a defensive pessimism strategy, which involves setting unrealistic low expectations in a risky situation and working through worst-case situations in an attempt to control anxiety (<xref ref-type="bibr" rid="redalyc_64752604016_ref3">Cantor &amp; Norem, 1989</xref>). </p>
<p> In conclusion, subjects who present a higher subjective risk value are the ones aware of their objective risk value (50%), the most educated individuals and the elderly, that is, the more informed and more experienced subjects. The way in which people approach and evaluate risks is, in fact, influenced by other people (<xref ref-type="bibr" rid="redalyc_64752604016_ref16">Joffe, 2003</xref>), namely closest people, who have or may have the disease. Accordingly, it can be stated that people’s emotional reactions to risk may often depend on the vividness with which negative consequences can be imagined or experienced (<xref ref-type="bibr" rid="redalyc_64752604016_ref32">Weber, 2006</xref>).</p>
<sec>
<title>Practice Implications</title>
<p>Knowledge of risk perception in
people at-risk for a hereditary neurodegenerative disease such as FAP allows
psychologists to offer appropriate counselling to patients about the potential
distress they might feel. Moreover, and as <xref ref-type="bibr" rid="redalyc_64752604016_ref19">Pelletier and Dorval (2004)</xref> have
also found, education and counselling in the context of genetic testing may
clarify misconceptions about hereditary diseases and help counselees and their
family members to make informed decisions about whether to undergo PST or not.</p>
</sec>
<sec>
<title>Human Studies and Informed Consent</title>
<p>All
procedures followed were in accordance with the ethical standards of the
responsible committee on human experimentation (institutional and national) and
with the Helsinki Declaration of 1975, as revised in 2000 (5). Informed consent
was obtained from all patients for their inclusion in the study.</p>
</sec>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="redalyc_64752604016_ref1">
<mixed-citation> Al-Rawad, M., &amp; Al Khattab, A. (2015). Risk perception in a developing country: The case of Jordan. <italic>International Business Research</italic>, <italic>8</italic>(1), 81-96. http://dx.doi.org/10.5539/ibr.v8n1p81</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al-Rawad</surname>
<given-names> M</given-names>
</name>
<name>
<surname>Al Khattab</surname>
<given-names> A.</given-names>
</name>
</person-group>
<article-title>Risk perception in a developing country: The
case of Jordan</article-title>
<source>International Business Research</source>
<year>2015</year>
<volume>8</volume>
<issue>1</issue>
<fpage>81</fpage>
<lpage>96</lpage>
<pub-id pub-id-type="doi">http://dx.doi.org/10.5539/ibr.v8n1p81</pub-id>
</element-citation>
</ref>
<ref id="redalyc_64752604016_ref2">
<mixed-citation> Brewer, N. T., Chapman, G. B., Gibbons, F. X., Gerrard, M., McCaul, K. D., &amp; Weinstein, N. D. (2007). Meta-analysis of the relationship between risk perception and health behavior: The example of vaccination. <italic>Health Psychology</italic>, <italic>26</italic>(2), 136-145. http://dx.doi.org/10.1037/0278-6133.26.2.136</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brewer</surname>
<given-names> N. T</given-names>
</name>
<name>
<surname>Chapman</surname>
<given-names> G. B</given-names>
</name>
<name>
<surname>Gibbons</surname>
<given-names> F. X</given-names>
</name>
<name>
<surname>Gerrard</surname>
<given-names> M</given-names>
</name>
<name>
<surname>McCaul</surname>
<given-names> K. D</given-names>
</name>
<name>
<surname>Weinstein</surname>
<given-names> N. D.</given-names>
</name>
</person-group>
<article-title>Meta-analysis of the relationship between risk perception and health
behavior: The example of vaccination</article-title>
<source>Health Psychology</source>
<year>2007</year>
<volume>26</volume>
<issue>2</issue>
<fpage>136</fpage>
<lpage>145</lpage>
<pub-id pub-id-type="doi">http://dx.doi.org/10.1037/0278-6133.26.2.136</pub-id>
</element-citation>
</ref>
<ref id="redalyc_64752604016_ref3">
<mixed-citation> Cantor, N., &amp; Norem, J. K. (1989). Defensive pessimism and stress coping. <italic>Social Cognition</italic>, <italic>7</italic>, 92-112. http://dx.doi.org/10.1521/soco.1989.7.2.92</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cantor</surname>
<given-names> N</given-names>
</name>
<name>
<surname>Norem</surname>
<given-names> J. K.</given-names>
</name>
</person-group>
<article-title>Defensive pessimism and stress coping</article-title>
<source>Social Cognition</source>
<year>1989</year>
<volume>7</volume>
<fpage>92</fpage>
<lpage>112</lpage>
<pub-id pub-id-type="doi">http://dx.doi.org/10.1521/soco.1989.7.2.92</pub-id>
</element-citation>
</ref>
<ref id="redalyc_64752604016_ref4">
<mixed-citation> Coelho, T., Maia, L. F., Martins da Silva, A., Waddington, M., Planté-Bordeneuve, V., Lozeron, P., … Grogan, D. R. (2012). Tafamidis for transthyretin familial amyloid polyneuropathy: A randomized, controlled trial. <italic>Neurology</italic>, <italic>79</italic>, 785-792. http://dx.doi.org/10.1212/WNL.0b013e3182661eb1</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coelho</surname>
<given-names> T</given-names>
</name>
<name>
<surname>Maia</surname>
<given-names> L. F</given-names>
</name>
<name>
<surname>Martins da Silva</surname>
<given-names> A</given-names>
</name>
<name>
<surname>Waddington</surname>
<given-names> M</given-names>
</name>
<name>
<surname>Planté-Bordeneuve</surname>
<given-names> V</given-names>
</name>
<name>
<surname>Lozeron</surname>
<given-names> P</given-names>
</name>
<name>
<surname>Grogan</surname>
<given-names> D. R.</given-names>
</name>
</person-group>
<article-title>Tafamidis for
transthyretin familial amyloid polyneuropathy: A randomized, controlled trial</article-title>
<source>Neurology</source>
<year>2012</year>
<volume>79</volume>
<fpage>785</fpage>
<lpage>792</lpage>
<pub-id pub-id-type="doi">http://dx.doi.org/10.1212/WNL.0b013e3182661eb1</pub-id>
</element-citation>
</ref>
<ref id="redalyc_64752604016_ref5">
<mixed-citation> Coutinho, P. (1976). Aspectos neurológicos da PAF. <italic>Boletim do Hospital</italic>, <italic>1</italic>, 27-34.</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coutinho</surname>
<given-names> P.</given-names>
</name>
</person-group>
<article-title>Aspectos
neurológicos da PAF</article-title>
<source>Boletim do Hospital</source>
<year>1976</year>
<volume>1</volume>
<fpage>27</fpage>
<lpage>34</lpage>
</element-citation>
</ref>
<ref id="redalyc_64752604016_ref6">
<mixed-citation> Cox, S. M., &amp; McKellin, W. (1999). ‘There’s this thing in our family’: Predictive testing and the construction of risk for Huntington Disease. <italic>Sociology of Health &amp; Illness</italic>, <italic>21</italic>(5), 622-646. http://dx.doi.org/10.1111/1467-9566.00176</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cox</surname>
<given-names> S. M</given-names>
</name>
<name>
<surname>McKellin</surname>
<given-names> W.</given-names>
</name>
</person-group>
<article-title>‘There’s this thing in our family’: Predictive testing and
the construction of risk for Huntington Disease</article-title>
<source>Sociology of Health &amp; Illness</source>
<year>1999</year>
<volume>21</volume>
<issue>5</issue>
<fpage>622</fpage>
<lpage>646</lpage>
<pub-id pub-id-type="doi">http://dx.doi.org/10.1111/1467-9566.00176</pub-id>
</element-citation>
</ref>
<ref id="redalyc_64752604016_ref7">
<mixed-citation> Darker, C., &amp; Phillips, A. (2016). Risk perception. In M. Gellman &amp; R. Turner (Eds.), <italic>Encyclopedia of Behavioral Medicine</italic> (pp. 1-3). New York: Springer-Verlag. http://dx.doi.org/10.1007/978-1-4614-6439-6_866-2 </mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Darker</surname>
<given-names> C</given-names>
</name>
<name>
<surname>Phillips</surname>
<given-names> A.</given-names>
</name>
</person-group>
<person-group person-group-type="editor">
<name>
<surname>Gellman</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Turner</surname>
<given-names>R.</given-names>
</name>
</person-group>
<source>Encyclopedia of Behavioral Medicine</source>
<year>2016</year>
<fpage>1</fpage>
<lpage>3</lpage>
<publisher-loc>New York</publisher-loc>
<publisher-name>Springer-Verlag</publisher-name>
<pub-id pub-id-type="doi">http://dx.doi.org/10.1007/978-1-4614-6439-6_866-2</pub-id>
</element-citation>
</ref>
<ref id="redalyc_64752604016_ref8">
<mixed-citation> Etchegary, H. (2011). 'I put it on the back burner most days': Living with chronic risk. <italic>Health</italic>, 15(6), 633-649. http://dx.doi.org/10.1177/1363459310364162</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Etchegary</surname>
<given-names> H.</given-names>
</name>
</person-group>
<article-title>'I
put it on the back burner most days': Living with chronic risk</article-title>
<source>Health</source>
<year>2011</year>
<volume>15</volume>
<issue>6</issue>
<fpage>633</fpage>
<lpage>649</lpage>
<pub-id pub-id-type="doi">http://dx.doi.org/10.1177/1363459310364162</pub-id>
</element-citation>
</ref>
<ref id="redalyc_64752604016_ref9">
<mixed-citation> Evers-Kiebooms, G., &amp; Decruyenaere, M. (1998). Predictive testing for Huntington's disease: A challenge for persons at risk and for professionals. <italic>Patient Education and Counseling</italic>, <italic>35</italic>, 15-26. http://dx.doi.org/10.1016/S0738-3991(98)00086-X </mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Evers-Kiebooms</surname>
<given-names> G</given-names>
</name>
<name>
<surname>Decruyenaere</surname>
<given-names> M.</given-names>
</name>
</person-group>
<article-title>Predictive testing for Huntington's disease: A
challenge for persons at risk and for professionals</article-title>
<source>Patient Education and Counseling</source>
<year>1998</year>
<volume>35</volume>
<fpage>15</fpage>
<lpage>26</lpage>
<pub-id pub-id-type="doi">http://dx.doi.org/10.1016/S0738-3991(98)00086-X</pub-id>
</element-citation>
</ref>
<ref id="redalyc_64752604016_ref10">
<mixed-citation> Evers-Kiebooms, G., &amp; Fryns, J. P. (1999). Conseil génétique dans les maladies neurodégénératives: Approche multidisciplinaire dans le diagnostic prédictif. In A. Brice &amp; D. F. Schorderet (Eds.), <italic>Neurogénétique: Affections hérédo-dégénératives, Collection Traité de neurologie</italic> (pp. 13-22). Paris: Doin.</mixed-citation>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Evers-Kiebooms</surname>
<given-names> G</given-names>
</name>
<name>
<surname>Fryns</surname>
<given-names> J. P.</given-names>
</name>
</person-group>
<person-group person-group-type="editor">
<name>
<surname>Brice</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Schorderet</surname>
<given-names>D. F.</given-names>
</name>
</person-group>
<source>Neurogénétique: Affections hérédo-dégénératives, Collection Traité de neurologie</source>
<year>1999</year>
<fpage>13</fpage>
<lpage>22</lpage>
<publisher-loc>Paris</publisher-loc>
<publisher-name>Doin</publisher-name>
</element-citation>
</ref>
<ref id="redalyc_64752604016_ref11">
<mixed-citation> Evers-Kiebooms, G., Welkenhuysen, M., Claes, E., Decruyenaere, M., &amp; Denayer, L. (2000). The psychological complexity of predictive testing for late onset neurogenetic diseases and hereditary cancers: implications for multidisciplinary counselling and for genetic education. <italic>Social Science &amp; Medicine</italic>, <italic>51</italic>(6), 831-841. http://dx.doi.org/10.1016/S0277-9536(00)00064-2</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Evers-Kiebooms</surname>
<given-names> G</given-names>
</name>
<name>
<surname>Welkenhuysen</surname>
<given-names> M</given-names>
</name>
<name>
<surname>Claes</surname>
<given-names> E</given-names>
</name>
<name>
<surname>Decruyenaere</surname>
<given-names> M</given-names>
</name>
<name>
<surname>Denayer</surname>
<given-names> L.</given-names>
</name>
</person-group>
<article-title>The
psychological complexity of predictive testing for late onset neurogenetic
diseases and hereditary cancers: implications for multidisciplinary counselling
and for genetic education</article-title>
<source>Social Science &amp; Medicine</source>
<year>2000</year>
<volume>51</volume>
<issue>6</issue>
<fpage>831</fpage>
<lpage>841</lpage>
<pub-id pub-id-type="doi">http://dx.doi.org/10.1016/S0277-9536(00)00064-2</pub-id>
</element-citation>
</ref>
<ref id="redalyc_64752604016_ref12">
<mixed-citation> Folstein, S. E., Franz, M. L., Jensen, B. A., Chase, G. A., &amp; Folstein, M. F. (1983). Conduct disorder and affective disorder among offspring of patients with Huntington's disease. <italic>Psychological Medicine</italic>, <italic>13</italic>(1), 45-52. http://dx.doi.org/10.1017/S0033291700050054</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Folstein</surname>
<given-names> S. E</given-names>
</name>
<name>
<surname>Franz</surname>
<given-names> M. L</given-names>
</name>
<name>
<surname>Jensen</surname>
<given-names> B. A</given-names>
</name>
<name>
<surname>Chase</surname>
<given-names> G. A</given-names>
</name>
<name>
<surname>Folstein</surname>
<given-names> M. F.</given-names>
</name>
</person-group>
<article-title>Conduct
disorder and affective disorder among offspring of patients with Huntington's
disease</article-title>
<source>Psychological Medicine</source>
<year>1983</year>
<volume>13</volume>
<issue>1</issue>
<fpage>45</fpage>
<lpage>52</lpage>
<pub-id pub-id-type="doi">http://dx.doi.org/10.1017/S0033291700050054</pub-id>
</element-citation>
</ref>
<ref id="redalyc_64752604016_ref13">
<mixed-citation> Hoffmann, T. C., &amp; Del Mar, C. (2015). Patients' expectations of the benefits and harms of treatments, screening, and tests: A systematic review. <italic>JAMA Internal Medicine</italic>, <italic>175</italic>(2), 274-286. http://dx.doi.org/10.1001/jamainternmed.2014.6016</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoffmann</surname>
<given-names> T. C</given-names>
</name>
<name>
<surname>Del Mar</surname>
<given-names> C.</given-names>
</name>
</person-group>
<article-title>Patients'
expectations of the benefits and harms of treatments, screening, and tests: A
systematic review</article-title>
<source>JAMA Internal Medicine</source>
<year>2015</year>
<volume>175</volume>
<issue>2</issue>
<fpage>274</fpage>
<lpage>286</lpage>
<pub-id pub-id-type="doi">http://dx.doi.org/10.1001/jamainternmed.2014.6016</pub-id>
</element-citation>
</ref>
<ref id="redalyc_64752604016_ref14">
<mixed-citation> Inouye, J. (2014). <italic>Risk perception: Theories, strategies, and next steps</italic>. Wellington: Campbell Institute.</mixed-citation>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Inouye</surname>
<given-names> J.</given-names>
</name>
</person-group>
<source>Risk perception: Theories, strategies, and next steps</source>
<year>2014</year>
<publisher-loc>Wellington</publisher-loc>
<publisher-name>Campbell Institute</publisher-name>
</element-citation>
</ref>
<ref id="redalyc_64752604016_ref15">
<mixed-citation> Jamieson, C. E. (2001). <italic>Genetic testing for late onset diseases: Current research practices and analysis of policy development</italic>. Ottawa: Health Canada Applied Research and Analysis Directorate. </mixed-citation>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Jamieson</surname>
<given-names> C. E.</given-names>
</name>
</person-group>
<source>Genetic testing for late onset diseases: Current research practices and analysis of policy development</source>
<year>2001</year>
<publisher-loc>Ottawa</publisher-loc>
<publisher-name>Health Canada Applied Research and Analysis Directorate</publisher-name>
</element-citation>
</ref>
<ref id="redalyc_64752604016_ref16">
<mixed-citation> Joffe, H. (2003). Risk: From perception to social representation. <italic>British Journal of Social Psychology</italic>, <italic>42</italic>(1), 55-73. http://dx.doi.org/10.1348/014466603763276126 </mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Joffe</surname>
<given-names> H.</given-names>
</name>
</person-group>
<article-title>Risk: From perception to social representation</article-title>
<source>British Journal of Social Psychology</source>
<year>2003</year>
<volume>42</volume>
<issue>1</issue>
<fpage>55</fpage>
<lpage>73</lpage>
<pub-id pub-id-type="doi">http://dx.doi.org/10.1348/014466603763276126</pub-id>
</element-citation>
</ref>
<ref id="redalyc_64752604016_ref17">
<mixed-citation> Lippman-Hand, A., &amp; Fraser, F. C. (1979). Genetic counselling – The postcounselling period: I. Parents' perceptions of uncertainty. <italic>American Journal Medicine Genetics</italic>, <italic>4</italic>(1), 51-71. http://dx.doi.org/10.1002/ajmg.1320040108 </mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lippman-Hand</surname>
<given-names> A</given-names>
</name>
<name>
<surname>Fraser</surname>
<given-names> F. C.</given-names>
</name>
</person-group>
<article-title>Genetic counselling – The
postcounselling period: I. Parents' perceptions of uncertainty</article-title>
<source>American Journal Medicine Genetics</source>
<year>1979</year>
<volume>4</volume>
<issue>1</issue>
<fpage>51</fpage>
<lpage>71</lpage>
<pub-id pub-id-type="doi">http://dx.doi.org/10.1002/ajmg.1320040108</pub-id>
</element-citation>
</ref>
<ref id="redalyc_64752604016_ref18">
<mixed-citation> Patenaude, A. F., Guttmacher, A. E., &amp; Collins, F. S. (2002). Genetic testing and psychology: New rules, new responsabilities. <italic>American Psychologist</italic>, <italic>57</italic>(4), 271-282.  http://dx.doi.org/10.1037/0003-066X.57.4.271</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patenaude</surname>
<given-names> A. F</given-names>
</name>
<name>
<surname>Guttmacher</surname>
<given-names> A. E</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names> F. S.</given-names>
</name>
</person-group>
<article-title>Genetic testing and psychology:
New rules, new responsabilities</article-title>
<source>American Psychologist</source>
<year>2002</year>
<volume>57</volume>
<issue>4</issue>
<fpage>271</fpage>
<lpage>282</lpage>
<pub-id pub-id-type="doi">http://dx.doi.org/10.1037/0003-066X.57.4.271</pub-id>
</element-citation>
</ref>
<ref id="redalyc_64752604016_ref19">
<mixed-citation> Pelletier, S., &amp; Dorval, M. (2004). Predictive genetic testing raises new professional challenges for psychologists. <italic>Canadian Psychology</italic>, <italic>45</italic>(1), 16-30. http://dx.doi.org/10.1037/h0086968</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pelletier</surname>
<given-names> S</given-names>
</name>
<name>
<surname>Dorval</surname>
<given-names> M.</given-names>
</name>
</person-group>
<article-title>Predictive genetic testing raises new professional challenges for
psychologists</article-title>
<source>Canadian Psychology</source>
<year>2004</year>
<volume>45</volume>
<issue>1</issue>
<fpage>16</fpage>
<lpage>30</lpage>
<pub-id pub-id-type="doi">http://dx.doi.org/10.1037/h0086968</pub-id>
</element-citation>
</ref>
<ref id="redalyc_64752604016_ref20">
<mixed-citation> Petersen, A. (2001). Biofantasies: Genetics and medicine in the print media. <italic>Social Science and Medicine</italic>, <italic>52</italic>(8), 1255-1268.  http://dx.doi.org/10.1016/S0277-9536(00)00229-X</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petersen</surname>
<given-names> A.</given-names>
</name>
</person-group>
<article-title>Biofantasies: Genetics and medicine in the print media</article-title>
<source>Social Science and Medicine</source>
<year>2001</year>
<volume>52</volume>
<issue>8</issue>
<fpage>1255</fpage>
<lpage>1268</lpage>
<pub-id pub-id-type="doi">http://dx.doi.org/10.1016/S0277-9536(00)00229-X</pub-id>
</element-citation>
</ref>
<ref id="redalyc_64752604016_ref21">
<mixed-citation> Quaid, K. A., Sims, S. L., Swenson, M. M., Harrison, J. M., Moskowitz, C., Stepanov, N., … Westphal, B. J. (2008). Living at risk: Concealing risk and preserving hope in Huntington disease. <italic>Journal Genetic Counseling</italic>, <italic>17</italic>(1), 117-128. http://dx.doi.org/10.1007/s10897-007-9133-0</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quaid</surname>
<given-names> K. A</given-names>
</name>
<name>
<surname>Sims</surname>
<given-names> S. L</given-names>
</name>
<name>
<surname>Swenson</surname>
<given-names> M. M</given-names>
</name>
<name>
<surname>Harrison</surname>
<given-names> J. M</given-names>
</name>
<name>
<surname>Moskowitz</surname>
<given-names> C</given-names>
</name>
<name>
<surname>Stepanov</surname>
<given-names> N</given-names>
</name>
<name>
<surname>Westphal</surname>
<given-names> B. J.</given-names>
</name>
</person-group>
<article-title>Living at risk: Concealing risk and
preserving hope in Huntington disease</article-title>
<source>Journal Genetic Counseling</source>
<year>2008</year>
<volume>17</volume>
<issue>1</issue>
<fpage>117</fpage>
<lpage>128</lpage>
<pub-id pub-id-type="doi">http://dx.doi.org/10.1007/s10897-007-9133-0</pub-id>
</element-citation>
</ref>
<ref id="redalyc_64752604016_ref22">
<mixed-citation> Sequeiros, J. (1996). Aconselhamento genético e teste preditivo na doença de Machado-Joseph. In J. Sequeiros (Ed.), <italic>O Teste Preditivo da doença de Machado-Joseph</italic> (pp. 33-48). Porto: UnIGENe, IBMC.</mixed-citation>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Sequeiros</surname>
<given-names> J.</given-names>
</name>
</person-group>
<person-group person-group-type="editor">
<name>
<surname>Sequeiros</surname>
<given-names>J.</given-names>
</name>
</person-group>
<source>O Teste Preditivo da doença de Machado-Joseph</source>
<year>1996</year>
<fpage>33</fpage>
<lpage>48</lpage>
<publisher-loc>Porto</publisher-loc>
<publisher-name>UnIGENe, IBMC</publisher-name>
</element-citation>
</ref>
<ref id="redalyc_64752604016_ref23">
<mixed-citation> Siaki, L. A., Loescher, L. J., &amp; Trego, L. L. (2013). Synthesis strategy: Building a culturally sensitive mid-range theory of risk perception using literary, quantitative, and qualitative methods. <italic>Journal of Advanced Nursing</italic>, <italic>69</italic>(3), 726-737. http://dx.doi.org/10.1111/j.1365-2648.2012.06096</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Siaki</surname>
<given-names> L. A</given-names>
</name>
<name>
<surname>Loescher</surname>
<given-names> L. J</given-names>
</name>
<name>
<surname>Trego</surname>
<given-names> L. L.</given-names>
</name>
</person-group>
<article-title>Synthesis strategy: Building a culturally sensitive mid-range theory of
risk perception using literary, quantitative, and qualitative methods</article-title>
<source>Journal of Advanced Nursing</source>
<year>2013</year>
<volume>69</volume>
<issue>3</issue>
<fpage>726</fpage>
<lpage>737</lpage>
<pub-id pub-id-type="doi">http://dx.doi.org/10.1111/j.1365-2648.2012.06096</pub-id>
</element-citation>
</ref>
<ref id="redalyc_64752604016_ref24">
<mixed-citation> Sjöberg, L. (2004). Principles of risk perception applied to gene technology. To overcome the resistance to applications of biotechnology, research on risk perception must take a closer look at the public's reasons for rejecting this technology. <italic>EMBO Reports</italic>, <italic>5</italic>(S1), S47-S51. http://dx.doi.org/10.1038/sj.embor.7400258</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sjöberg</surname>
<given-names> L.</given-names>
</name>
</person-group>
<article-title>Principles of risk perception applied to gene technology. To
overcome the resistance to applications of biotechnology, research on risk
perception must take a closer look at the public's reasons for rejecting this
technology</article-title>
<source>EMBO Reports</source>
<year>2004</year>
<volume>5</volume>
<fpage>S47</fpage>
<lpage>S51</lpage>
<pub-id pub-id-type="doi">http://dx.doi.org/10.1038/sj.embor.7400258</pub-id>
<supplement>S1</supplement>
</element-citation>
</ref>
<ref id="redalyc_64752604016_ref25">
<mixed-citation> Sjöberg, L. (2012). Risk perception and societal response. In <italic>Handbook of risk theory</italic> (pp. 661-675). Netherlands: Springer.</mixed-citation>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Sjöberg</surname>
<given-names> L.</given-names>
</name>
</person-group>
<source>Handbook of risk theory</source>
<year>2012</year>
<fpage>661</fpage>
<lpage>675</lpage>
<publisher-loc>Netherlands</publisher-loc>
<publisher-name>Springer</publisher-name>
</element-citation>
</ref>
<ref id="redalyc_64752604016_ref26">
<mixed-citation> Sjöberg, L., Moen, B. -E., &amp; Rundmo, T. (2004). <italic>Explaining risk perception. An evaluation of the psychometric paradigm in risk perception research</italic>. Trondheim: Rotunde Publikasjoner.</mixed-citation>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Sjöberg</surname>
<given-names> L</given-names>
</name>
<name>
<surname>Moen</surname>
<given-names> B. -E</given-names>
</name>
<name>
<surname>Rundmo</surname>
<given-names> T.</given-names>
</name>
</person-group>
<source>Explaining risk perception. An evaluation of the psychometric paradigm in risk perception research</source>
<year>2004</year>
<publisher-loc>Trondheim</publisher-loc>
<publisher-name>Rotunde Publikasjoner</publisher-name>
</element-citation>
</ref>
<ref id="redalyc_64752604016_ref27">
<mixed-citation> Slovic, P. (1987). Perception of risk. <italic>Science</italic>, <italic>236</italic>(4799), 280-285. http://dx.doi.org/10.2307/1698637</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Slovic</surname>
<given-names> P.</given-names>
</name>
</person-group>
<article-title>Perception of risk</article-title>
<source>Science</source>
<year>1987</year>
<volume>236</volume>
<issue>4799</issue>
<fpage>280</fpage>
<lpage>285</lpage>
<pub-id pub-id-type="doi">http://dx.doi.org/10.2307/1698637</pub-id>
</element-citation>
</ref>
<ref id="redalyc_64752604016_ref28">
<mixed-citation> Slovic, P., &amp; Elke, W. (2002, April). <italic>Perception of risk posed by extreme events</italic>. Paper presented at the Conference Risk Management Strategies in an Uncertain World, New York. Retrieved from  <ext-link ext-link-type="uri" xlink:href="https://www.ldeo.columbia.edu/chrr/documents/meetings/roundtable/pdf/roundtable_exec_final.pdf">https://www.ldeo.columbia.edu/chrr/documents/meetings/roundtable/pdf/roundtable_exec_final.pdf</ext-link> </mixed-citation>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Slovic</surname>
<given-names> P</given-names>
</name>
<name>
<surname>Elke</surname>
<given-names> W.</given-names>
</name>
</person-group>
<source>Perception of risk posed by extreme events</source>
<year>2002</year>
<comment> <ext-link ext-link-type="uri" xlink:href="https://www.ldeo.columbia.edu/chrr/documents/meetings/roundtable/pdf/roundtable_exec_final.pdf">https://www.ldeo.columbia.edu/chrr/documents/meetings/roundtable/pdf/roundtable_exec_final.pdf</ext-link> </comment>
<conf-name>Conference Risk Management Strategies in an Uncertain World</conf-name>
<conf-loc>New York</conf-loc>
</element-citation>
</ref>
<ref id="redalyc_64752604016_ref29">
<mixed-citation> Slovic, P., &amp; Peters, E. (2006). Risk perception and affect. <italic>Current Directions in Psychological Science</italic>, <italic>15</italic>, 6322-325. http://dx.doi.org/10.1111/j.1467-8721.2006.00461</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Slovic</surname>
<given-names> P</given-names>
</name>
<name>
<surname>Peters</surname>
<given-names> E.</given-names>
</name>
</person-group>
<article-title>Risk perception and affect</article-title>
<source>Current Directions in Psychological Science</source>
<year>2006</year>
<volume>15</volume>
<fpage>6322</fpage>
<lpage>6325</lpage>
<pub-id pub-id-type="doi">http://dx.doi.org/10.1111/j.1467-8721.2006.00461</pub-id>
</element-citation>
</ref>
<ref id="redalyc_64752604016_ref30">
<mixed-citation> Taylor, S. D. (2003). Predictive testing for an individual at 25% risk for Huntington’s disease: Present conundrums, future challenges. <italic>Journal of Futures Studies</italic>, <italic>7</italic>(4), 27-36.</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taylor</surname>
<given-names> S. D.</given-names>
</name>
</person-group>
<article-title>Predictive testing for an individual at 25% risk for Huntington’s
disease: Present conundrums, future challenges</article-title>
<source>Journal of Futures Studies</source>
<year>2003</year>
<volume>7</volume>
<issue>4</issue>
<fpage>27</fpage>
<lpage>36</lpage>
</element-citation>
</ref>
<ref id="redalyc_64752604016_ref31">
<mixed-citation> Ulleberg, P., &amp; Rundmo, T. (1996, September). <italic>Risk perception, affectivity and health</italic>. Presented at the 10th Conference of European Health Psychology, Dublin, Ireland.</mixed-citation>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Ulleberg</surname>
<given-names> P</given-names>
</name>
<name>
<surname>Rundmo</surname>
<given-names> T.</given-names>
</name>
</person-group>
<source>Risk perception, affectivity and health</source>
<year>1996</year>
<conf-name>10th Conference of European Health Psychology</conf-name>
<conf-loc>Dublin, Ireland</conf-loc>
</element-citation>
</ref>
<ref id="redalyc_64752604016_ref32">
<mixed-citation> Weber, E. U. (2006). Evidence-based and description-based perceptions of long term risk: Why global warming does not scare us (yet). <italic>Climatic Change</italic>, <italic>77</italic>(1-2), 103-120. http://dx.doi.org/10.1007/s10584-006-9060-3</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weber</surname>
<given-names> E. U.</given-names>
</name>
</person-group>
<article-title>Evidence-based and description-based perceptions of long term risk: Why global
warming does not scare us (yet)</article-title>
<source>Climatic Change</source>
<year>2006</year>
<volume>77</volume>
<issue>1-2</issue>
<fpage>103</fpage>
<lpage>120</lpage>
<pub-id pub-id-type="doi">http://dx.doi.org/10.1007/s10584-006-9060-3</pub-id>
</element-citation>
</ref>
<ref id="redalyc_64752604016_ref33">
<mixed-citation> Wexler, N. S. (1979). Genetic “russian roulette”: The experience of being "at risk" for Huntington's disease. In S. Kessler (Ed.), <italic>Genetic counselling: Psychological dimensions</italic> (pp. 199-220). London: Academic Press. </mixed-citation>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Wexler</surname>
<given-names> N. S.</given-names>
</name>
</person-group>
<person-group person-group-type="editor">
<name>
<surname>Kessler</surname>
<given-names>S.</given-names>
</name>
</person-group>
<source>Genetic counselling: Psychological dimensions</source>
<year>1979</year>
<fpage>199</fpage>
<lpage>220</lpage>
<publisher-loc>London</publisher-loc>
<publisher-name>Academic Press</publisher-name>
</element-citation>
</ref>
</ref-list>
<fn-group>
<title>Notes</title>
<fn id="fn1" fn-type="other">
<label>
<sup>*</sup>
</label>
<p>Research article.</p>
</fn>
</fn-group>
</back>
</article>